ARCHIVES

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010